PPARD and primary biliary cholangitis: Seladelpar significantly decreased bile acid precursor 7 alpha-hydroxy-4-cholesten-3-one (C4) and total bile acids in patients with PBC (12, 13), indicating that PPARD reduces bile acid synthesis, in humans.